$160.42 -2.30 (%) Alexion Pharmaceuticals Inc - NASDAQ

Sep. 15, 2014 | 04:00 PM

Partner Headlines

  1. Nasdaq Falls Hard, But Apple Resilient On iPhone Orders

    IBD | Sep. 15, 2014 | 14:55PM EST
  2. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  3. Stocks Turn Higher After Soft Start; U.S. Silica Jumps

    IBD | Sep. 10, 2014 | 13:25PM EST
  4. Stocks Up At Midday; Alexion Leads Biotech Rebound

    IBD | Sep. 10, 2014 | 11:54AM EST
  5. Alexion Pharmaceuticals: FDA Findings An Easy Fix

    IBD | Sep. 5, 2014 | 18:45PM EST
  6. Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs

    IBD | Aug. 25, 2014 | 14:54PM EST
  7. UPDATE: 8-K from Alexion Pharma Shows FDA Issued Form 483 at Aug. Inspection of Site, Does Not Expect Material Financial Effect Related to FDA Concern

    Benzinga | Aug. 25, 2014 | 07:53AM EST
  8. Alexion Initiates Multinational Registration Trial of Eculizumab for Prevention of DGF after Kidney Transplantation

    Benzinga | Aug. 25, 2014 | 06:32AM EST
  9. Jazz, Celgene Lead Top 4 Drugmaker Profit Margins

    IBD | Aug. 18, 2014 | 13:46PM EST
  10. Alexion CEO Receives Nearly $17 Million for Sale of Company Stock

    GuruFocus | Aug. 14, 2014 | 16:02PM EST
  11. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD | Aug. 8, 2014 | 16:45PM EST
  12. Here's How Facebook, Alexion Teach Lessons In Tenacity

    IBD | Aug. 7, 2014 | 18:02PM EST
  13. European Commission Grants Orphan Drug Designation To Soliris (eculizumab) For The Treatment Of Patients With Myasthenia Gravis (MG)

    Benzinga | Aug. 1, 2014 | 06:58AM EST
  14. Many Leading Stocks Damaged As Market Tumbles Broadly

    IBD | Jul. 31, 2014 | 14:51PM EST
  15. Stocks Feint Higher, Then Slip; Pending Home Sales Down In June

    IBD | Jul. 28, 2014 | 10:34AM EST
  16. Biotechs Fall Despite Beats

    IBD | Jul. 24, 2014 | 18:55PM EST
  17. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD | Jul. 24, 2014 | 17:07PM EST
  18. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD | Jul. 24, 2014 | 11:39AM EST
  19. Stocks Up And Down At Open; Under Armour, Facebook Surge

    IBD | Jul. 24, 2014 | 10:31AM EST
  20. US Stock Futures Gain Ahead Of Earnings, Economic Data

    Benzinga | Jul. 24, 2014 | 07:39AM EST
  21. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD | Jul. 23, 2014 | 18:17PM EST
  22. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD | Jul. 23, 2014 | 16:16PM EST
  23. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD | Jul. 23, 2014 | 13:29PM EST
  24. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD | Jul. 23, 2014 | 11:56AM EST
  25. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD | Jul. 22, 2014 | 12:42PM EST
  26. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD | Jul. 22, 2014 | 10:32AM EST
  27. IBD 50 Ends Week Lower But Skyworks Soars

    IBD | Jul. 21, 2014 | 18:47PM EST
  28. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD | Jul. 19, 2014 | 08:02AM EST
  29. IBD 50 Ends Week Lower But Skyworks Soars

    IBD | Jul. 18, 2014 | 18:47PM EST
  30. Will New Drug Give Alexion Pharmaceuticals A Boost?

    IBD | Jul. 18, 2014 | 18:47PM EST
  31. Inside The IBD 50: Leaders Show Mixed Action

    IBD | Jul. 11, 2014 | 18:50PM EST
  32. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD | Jul. 11, 2014 | 18:50PM EST
  33. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD | Jul. 8, 2014 | 14:42PM EST
  34. Raptor Announces CEO Succession Plan; Dr. Christopher Starr To Retire As CEO At Year-End 2014, Julie Anne Smith Named President And CEO-Designate

    Benzinga | Jul. 7, 2014 | 16:01PM EST
  35. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga | Jul. 3, 2014 | 12:26PM EST
  36. 4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

    Benzinga | Jul. 3, 2014 | 10:36AM EST
  37. Stocks Mixed As Losses Pared; Foot Locker Steps Up

    IBD | Jun. 27, 2014 | 12:03PM EST
  38. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD | Jun. 20, 2014 | 18:35PM EST
  39. Techs, Small Cap Stocks Lead; Family Dollar Heads Group Rally

    IBD | Jun. 9, 2014 | 15:17PM EST
  40. After The Biotech Sell-off, How Will Investors Treat Alexion Pharmaceuticals?

    IBD | May. 9, 2014 | 12:03PM EST
  41. Alexion, Priceline, OpenTable: A Top Manager's View

    IBD | May. 6, 2014 | 18:54PM EST
  42. Market Wrap For May 5: Dow Erases Triple-Digit Loss, All Three Major Indices Positive

    Benzinga | May. 5, 2014 | 16:36PM EST
  43. US Stock Futures Decline After China Data

    Benzinga | May. 5, 2014 | 07:29AM EST
  44. Earnings Growth Anemic But Medical Sector Healthy

    IBD | May. 2, 2014 | 18:54PM EST
  45. Kors Among 5 Stocks With Superior 3-Year EPS Growth

    IBD | May. 1, 2014 | 08:02AM EST
  46. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD | Apr. 25, 2014 | 18:51PM EST
  47. Alexion Tops, Celgene Mixed

    IBD | Apr. 24, 2014 | 18:46PM EST
  48. Stocks Mixed In Late Trade; Goodyear Breaks Out

    IBD | Apr. 24, 2014 | 14:51PM EST
  49. Nasdaq Leads As Indexes Reverse Upward

    IBD | Apr. 24, 2014 | 12:11PM EST
  50. Alexion, Celgene Report Contrasting Q1 Earnings

    IBD | Apr. 24, 2014 | 11:39AM EST
Trading Center